Medicare Enrolled
Dr. Amy Reese, M.D.
Hematology & Oncology · Sandusky, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reese from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reese?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reese
Dr. Amy Reese is a hematology & oncology specialist in Sandusky, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Reese performed 899 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Reese received a total of $8,607 from 64 pharmaceutical and/or device companies across 356 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reese is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 38% volume in OH
$8,607 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗899
Medicare services
Top 38% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
423 | $73 | $240 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
180 | $47 | $160 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
173 | $113 | $330 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
37 | $132 | $370 |
| New patient office visit, complex (60-74 min) | 27 | $136 | $400 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
22 | $52 | $185 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $88 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $87 | $310 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
12 | $76 | $265 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,607
Total received (2018-2024)
Avg $1,230/year across 7 years
Top 31% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
356
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,810
2023
$1,332
2022
$1,810
2021
$864
2020
$331
2019
$1,167
2018
$1,293
Payments by company (2024)
Incyte Corporation
$183
GENZYME CORPORATION
$159
PFIZER INC.
$127
Novartis Pharmaceuticals Corporation
$123
Merck Sharp & Dohme LLC
$111
Astellas Pharma US Inc
$109
Lilly USA, LLC
$104
Genmab U.S., Inc.
$75
ABBVIE INC.
$74
AstraZeneca Pharmaceuticals LP
$72
Celgene Corporation
$72
Coherus Biosciences Inc.
$69
Sirtex Medical Inc
$64
E.R. Squibb & Sons, L.L.C.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$57
Janssen Biotech, Inc.
$41
Blueprint Medicines Corporation
$36
Bayer Healthcare Pharmaceuticals Inc.
$32
Stemline Therapeutics Inc.
$25
ADC Therapeutics America, Inc.
$24
TAIHO ONCOLOGY, INC.
$24
Aveo Pharmaceuticals, Inc.
$23
GlaxoSmithKline, LLC.
$23
Genentech USA, Inc.
$21
Eisai Inc.
$19
Gilead Sciences, Inc.
$18
ARRAY BIOPHARMA INC
$17
Daiichi Sankyo Inc.
$16
Rigel Pharmaceuticals, Inc.
$16
Novocure Inc.
$15
Top 3 companies account for 25.9% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$1,136
E.R. Squibb & Sons, L.L.C.
$640
Novartis Pharmaceuticals Corporation
$627
AstraZeneca Pharmaceuticals LP
$505
Genentech USA, Inc.
$430
Merck Sharp & Dohme LLC
$337
Janssen Biotech, Inc.
$308
Seagen Inc.
$290
Celgene Corporation
$268
PFIZER INC.
$266
Merck Sharp & Dohme Corporation
$253
GENZYME CORPORATION
$242
Lilly USA, LLC
$229
JAZZ PHARMACEUTICALS INC.
$227
Amgen Inc.
$203
Exelixis Inc.
$189
Bayer HealthCare Pharmaceuticals Inc.
$181
Astellas Pharma US Inc
$128
Pharmacyclics LLC, An AbbVie Company
$126
Coherus Biosciences Inc.
$107
Takeda Pharmaceuticals U.S.A., Inc.
$106
Blueprint Medicines Corporation
$97
ABBVIE INC.
$93
Daiichi Sankyo Inc.
$92
Kite Pharma, Inc.
$87
Genmab U.S., Inc.
$75
Janssen Products, LP
$75
Bayer Healthcare Pharmaceuticals Inc.
$72
Eisai Inc.
$67
Gilead Sciences, Inc.
$65
Sirtex Medical Inc
$64
GlaxoSmithKline, LLC.
$62
MorphoSys, US Inc.
$60
ADC Therapeutics America, Inc.
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Pharmacyclics LLC, an AbbVie Company
$51
Adaptive Biotechnologies Corporation
$50
ARRAY BIOPHARMA INC
$50
Epizyme, Inc.,
$47
Blue Earth Diagnostics Limited
$47
TESARO, Inc.
$43
Rigel Pharmaceuticals, Inc.
$32
AMAG Pharmaceuticals, Inc.
$31
Janssen Pharmaceuticals, Inc
$29
Seattle Genetics, Inc.
$29
Clovis Oncology, Inc.
$28
EMD Serono, Inc.
$26
Apellis Pharmaceuticals, Inc.
$25
Stemline Therapeutics Inc.
$25
Tolmar, Inc.
$25
TAIHO ONCOLOGY, INC.
$24
Aveo Pharmaceuticals, Inc.
$23
AVEO Pharmaceuticals, Inc.
$22
EISAI INC.
$20
G1 Therapeutics, Inc.
$19
Otsuka America Pharmaceutical, Inc.
$19
AbbVie, Inc.
$19
Helsinn Therapeutics (U.S.), Inc.
$18
BeiGene USA, Inc.
$17
Kyowa Kirin, Inc.
$15
Novocure Inc.
$15
TerSera Therapeutics LLC
$14
Taiho Oncology, Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 27.9% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · Avastin · Axumin · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · Idhifa · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MVASI · NINLARO · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · Stivarga · TAFINLAR · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TEPMETKO · TUKYSA · Tavalisse · Tecentriq · Tivdak · Trodelvy · UBRELVY · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · XALKORI · XARELTO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
8
County median income
$68,431
Nearest hospital to ZIP centroid (approximate)
FIRELANDS REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reese is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reese experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Reese performed 423 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Reese receive payments from pharmaceutical companies?
Yes. Dr. Reese received a total of $8,607 from 64 companies across 356 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reese's costs compare to other hematology & oncology specialists in Sandusky?
Dr. Reese's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reese) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Sandusky
Browse hematology & oncology specialists in Sandusky ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology